Sure! Here’s the translation to American English:
Samsung Medison has captured the attention of the international medical community with its innovative range of ultrasound diagnostic solutions, aimed at addressing various stages of a woman’s life, from the fetal stage to menopause. During the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG 2025) event taking place in Cancun, Mexico, the company will present its comprehensive approach to women’s health under the slogan “From Challenges to Solutions: Experience Innovation.”
One of the highlights of the update to the HERA Z20, which will be showcased at the event, is its commitment to personalized diagnostics based on each phase of a woman’s life. This equipment enables healthcare professionals to manage women’s health comprehensively, providing specialized support from adolescence to aging.
PelvicAssist™, one of the new additions, automatically analyzes multiple pelvic regions and measures the levator hiatus area, providing 3D imaging that helps to better understand female anatomy. Since anatomical structures require considerable time for evaluation, Samsung Medison offers a tailored diagnostic solution, simplifying reports for conditions like uterine fibroids. The Fibroid 2D tool applies the guidelines of the International Federation of Gynecology and Obstetrics (FIGO), optimizing the diagnostic procedure.
The company has also redesigned the ultra-compact Mini ER7 probe, which is 63% smaller than conventional probes. This development aims to reduce discomfort during gynecological exams, particularly benefiting adolescent and elderly patients.
With the increase of high-risk pregnancies, Samsung Medison has included a new feature called Ophthalmic Artery. This technology allows for the early detection of systemic vasoconstriction, a key indicator of preeclampsia. Since the ophthalmic artery branches directly from the internal carotid artery, it facilitates indirect monitoring of cerebral blood flow, contributing to the early detection of potential cardiovascular complications.
Innovation is also focused on increasing the efficiency of healthcare professionals. Live ViewAssist™ allows for the automatic extraction of up to 39 cross-sectional images, providing not only automated annotations but also measurement results for key parameters throughout the pregnancy cycle. This tool aims to drastically reduce the time required for accurate diagnosis.
Jihyun Kim, head of the CX group at Samsung Medison, emphasized: “The enhanced HERA 20 is more than just an update; it is a comprehensive solution designed to support women’s health at all stages of life. By combining artificial intelligence technology with clinical expertise, we aim to improve diagnostic accuracy and reduce burdens, catalyzing significant change in healthcare.”
via: MiMub in Spanish
